8-K current report · filed Oct 29, 2026

Pediatrix Medical Group, Inc. (MD) 8-K Current Report: October 29, 2026

Item 2.02Item EX-99.1MD overview

Short answer

Pediatrix Medical Group, Inc. (MD) filed an 8-K current report with the SEC on October 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Third-quarter results announcement for the three and nine months ended September 30, 2026.

Pediatrix Medical Group, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Third-quarter results announcement for the three and nine months ended September 30, 2026
  • Press release dated October 29, 2026, contains operating results and financial details
  • Exhibit 99.1 is the key source for revenue, earnings, cash flow and outlook metrics

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $501.4M, up 1.7%, with same-unit growth 0.6% and acquisitions contributing 1.1%
  • Adjusted EPS $0.72 versus $0.67, despite GAAP EPS declining to $0.59 from $0.84
  • Adjusted EBITDA $85.5M versus $87.3M, signaling expense pressure at existing units despite acquisition benefits
  • Nine-month Adjusted EBITDA $220.1M versus $209.7M, supporting full-year guidance of $290M to $300M
  • $83.0M share repurchases reduced diluted shares to 79.7M, while cash fell to $311.9M and debt stood at $578M

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Pediatrix Medical Group, Inc. 8-K filings

Get the next MD 8-K as it lands

Follow MD for push alerts, or ask the research agent what this filing means.